ipatasertib (Tablet)

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

CancerHealthy Volunteer

Phase 1

A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers

CompletedNCT02063581

Genentech, Inc.Healthy Volunteer

Start: 2014-02-28End: 2014-03-31Updated: 2016-11-02

Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects

CompletedNCT02536391

Genentech, Inc.Cancer

Start: 2015-10-31End: 2015-11-30Updated: 2016-11-02

Related Papers

Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib.

2021-09-016 citations